Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders

Antibody Link for VITT and VITT-like DisordersThe antibody that mediates the occurrence of VITT associated with adenoviral-based Covid-19 vaccines is nearly identical to the antibodies produced in response to natural adenoviral infection.

Saved in:
Bibliographic Details
Published inThe New England journal of medicine Vol. 390; no. 19; pp. 1827 - 1829
Main Authors Wang, Jing Jing, Schönborn, Linda, Warkentin, Theodore E., Chataway, Tim, Grosse, Leonie, Simioni, Paolo, Moll, Stephan, Greinacher, Andreas, Gordon, Tom P.
Format Journal Article
LanguageEnglish
Published United States Massachusetts Medical Society 16.05.2024
Subjects
Ad26COVS1 - adverse effects
Ad26COVS1 - immunology
Adenoviridae
Adenovirus Infections, Human - complications
Adenovirus Infections, Human - immunology
Adenovirus Infections, Human - virology
Adenoviruses
Allergy
Amino acids
Antibodies
Antibodies, Viral - blood
Antigens
Autoantibodies - blood
Autoantibodies - immunology
Autoimmune Disease
Binding sites
ChAdOx1 nCoV-19 - adverse effects
ChAdOx1 nCoV-19 - immunology
Coagulation
Coronavirus
Coronaviruses
COVID-19 vaccines
Hematology
Humans
Immunization
Immunoglobulins
Immunology
Infections
Infectious Disease
Light
Oncology
Patients
Platelet Factor 4 - immunology
Purpura, Thrombocytopenic, Idiopathic - etiology
Purpura, Thrombocytopenic, Idiopathic - immunology
Thrombocytopenia
Thrombosis
Vaccines
Viral Infections
Online AccessGet full text

Cover

More Information
Summary:Antibody Link for VITT and VITT-like DisordersThe antibody that mediates the occurrence of VITT associated with adenoviral-based Covid-19 vaccines is nearly identical to the antibodies produced in response to natural adenoviral infection.
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 14
content type line 23
ISSN:0028-4793
1533-4406
1533-4406
DOI:10.1056/NEJMc2402592